Brief: IX Biopharma Gets Allowance Notice From U.S. Patent And Trademark Office For Application
09/06/2020 07:18
June 9 (Reuters) - IX Biopharma Ltd IXBI.SI :
* U.S. PATENT AND TRADEMARK OFFICE ISSUED NOTICE OF
ALLOWANCE FOR
PATENT APPLICATION ENTITLED "FAST DISSOLVING SOLID DOSAGE FORM"
* UPON ISSUANCE, US PATENT EXPECTED TO EXPIRE NO EARLIER
THAN OCT
2030
Source text for Eikon: ID:nSNZ31g0gB
Further company coverage: IXBI.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IX Biopharma
See all newsBrief: IX Biopharma Says Co Will Undertake An Internal Restructuring Of Its Consumer Business
Brief: IX Biopharma To Issue 1 MLN New Shares To Anson Properties At S$0.4215 Per Share
Brief: IX Biopharma Says US Government Awards US$41 MLN Contract To Fund Development Of Wafermine
Brief: IX Biopharma To Raise At Least S$6 MLN Via Placement At S$0.198 Per Share
Brief: IX Biopharma Enters Term Sheet For Proposed Joint Venture